▶ 調査レポート

世界の姿勢起立性頻脈症候群（POTS）の治療市場：市場規模・現状・予測
• 英文タイトル：Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の姿勢起立性頻脈症候群（POTS）の治療市場：市場規模・現状・予測 / Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7871資料のイメージです。• レポートコード：QYR9N7871
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、姿勢起立性頻脈症候群（POTS）の治療のグローバル市場について調査・分析したレポートで、種類別（一次フォーム、二次フォーム）、用途別（病院、診療所、外来手術センター、研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・姿勢起立性頻脈症候群（POTS）の治療の世界市場規模
・主要企業別市場シェア
・姿勢起立性頻脈症候群（POTS）の治療の世界市場規模：種類別（一次フォーム、二次フォーム）
・姿勢起立性頻脈症候群（POTS）の治療の世界市場規模：用途別（病院、診療所、外来手術センター、研究機関）
・姿勢起立性頻脈症候群（POTS）の治療のアメリカ市場規模（種類別、用途別）
・姿勢起立性頻脈症候群（POTS）の治療のヨーロッパ市場規模（種類別、用途別）
・姿勢起立性頻脈症候群（POTS）の治療の中国市場規模（種類別、用途別）
・姿勢起立性頻脈症候群（POTS）の治療の日本市場規模（種類別、用途別）
・姿勢起立性頻脈症候群（POTS）の治療の東南アジア市場規模（種類別、用途別）
・姿勢起立性頻脈症候群（POTS）の治療のインド市場規模（種類別、用途別）
・姿勢起立性頻脈症候群（POTS）の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・姿勢起立性頻脈症候群（POTS）の治療の世界市場予測（2019年-2025年）
・姿勢起立性頻脈症候群（POTS）の治療の地域別市場予測（2019年-2025年）
...

Postural orthostatic tachycardia syndrome (POTS) is a condition in which a change from lying to standing causes an abnormally large increase in heart rate.Postural orthostatic tachycardia syndrome treatment may include avoiding factors that bring on symptoms, increasing dietary salt and water, compression stockings, exercise, cognitive behavioral therapy and medications.
In 2018, the global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Postural Orthostatic Tachycardia Syndrome (POTS) Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Novartis
AstraZeneca
Merck
Sanofi
Daiichi Sankyo
Bayer
…

Market segment by Type, the product can be split into
Primary Forms
Secondary Forms

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Research Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Postural Orthostatic Tachycardia Syndrome (POTS) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Postural Orthostatic Tachycardia Syndrome (POTS) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Primary Forms
1.4.3 Secondary Forms
1.5 Market by Application
1.5.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size
2.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Growth Trends by Regions
2.2.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions (2014-2025)
2.2.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Manufacturers
3.1.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players Head office and Area Served
3.3 Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product/Solution/Service
3.4 Date of Enter into Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2014-2019)
4.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2014-2019)
5.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in United States
5.3 United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
5.4 United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application

6 Europe
6.1 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2014-2019)
6.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Europe
6.3 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
6.4 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application

7 China
7.1 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2014-2019)
7.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in China
7.3 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
7.4 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application

8 Japan
8.1 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2014-2019)
8.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Japan
8.3 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
8.4 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2014-2019)
9.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
9.4 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application

10 India
10.1 India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2014-2019)
10.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in India
10.3 India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
10.4 India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2014-2019)
11.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Central & South America
11.3 Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
11.4 Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
12.1.4 Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
12.2.4 Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
12.3.4 AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
12.4.4 Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
12.5.4 Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 Daiichi Sankyo
12.6.1 Daiichi Sankyo Company Details
12.6.2 Company Description and Business Overview
12.6.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
12.6.4 Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
12.6.5 Daiichi Sankyo Recent Development
12.7 Bayer
12.7.1 Bayer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
12.7.4 Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
12.7.5 Bayer Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Market Segments
Table Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Covered
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Market Share by Type 2014-2025
Figure Primary Forms Figures
Table Key Players of Primary Forms
Figure Secondary Forms Figures
Table Key Players of Secondary Forms
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Research Institutes Case Studies
Figure Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Report Years Considered
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size 2014-2025 (Million US$)
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions 2014-2019
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions 2014-2019
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Manufacturers in 2018
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product/Solution/Service
Table Date of Enter into Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Type (2014-2019)
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Market Share by Type (2014-2019)
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Application (2014-2019)
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Application in 2018
Figure United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2018-2019)
Table United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2014-2019)
Table United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2014-2019)
Figure Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2018-2019)
Table Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2014-2019)
Table Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2014-2019)
Figure China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2018-2019)
Table China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2014-2019)
Table China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2014-2019)
Figure Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2018-2019)
Table Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2014-2019)
Table Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2018-2019)
Table Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2014-2019)
Figure India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2018-2019)
Table India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2014-2019)
Table India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2014-2019)
Figure Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2018-2019)
Table Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2014-2019)
Table Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
Table Novartis Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Merck Company Details
Table Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table Bayer Company Details
Table Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2014-2019)
Table Bayer Recent Development
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Regions (2019-2025)
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Regions in 2025
Figure United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Product (2019-2025)
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Product in 2025
Table Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2019-2025)
Figure Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の物質使用障害（SUD）の治療市場：市場規模・現状・予測
    Global Substance Use Disorders (SUDs) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8091 2019年6月14日 98Pages
    当資料は、物質使用障害（SUD）の治療のグローバル市場について調査・分析したレポートで、種類別（オピオイド中毒、タバコ/ニコチン中毒、アルコール依存）、用途別（病院と診療所、住居（病院以外））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...
  • 世界の炎症性腸疾患（IBD）の治療市場：市場規模・現状・予測
    Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7362 2019年6月14日 98Pages
    当資料は、炎症性腸疾患（IBD）の治療のグローバル市場について調査・分析したレポートで、種類別（TNF阻害剤、アミノサリチル酸、免疫調節剤、コルチコステロイド）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予...
  • 世界の性感染症（STD）の治療市場：市場規模・現状・予測
    Global Sexually Transmitted Diseases (STD) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8027 2019年6月14日 97Pages
    当資料は、性感染症（STD）の治療のグローバル市場について調査・分析したレポートで、種類別（ウイルス感染、細菌感染、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の巣状分節性糸球体硬化症（FSGS）の治療市場：市場規模・現状・予測
    Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7216 2019年6月14日 92Pages
    当資料は、巣状分節性糸球体硬化症（FSGS）の治療のグローバル市場について調査・分析したレポートで、種類別（薬物療法、透析、腎臓移植）、用途別（一次FSGS、二次FSGS）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...
  • 世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測
    Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7488 2019年6月14日 97Pages
    当資料は、リソソーム酸リパーゼ欠乏症（LAAL）の治療のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、腎臓移植、幹細胞移植）、用途別（ウォルマン病、コレステロールエステル蓄積症（CESD））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...
  • 世界のクッシング症候群の治療市場：市場規模・現状・予測
    Global Cushing's Syndrome Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7049 2019年6月14日 93Pages
    当資料は、クッシング症候群の治療のグローバル市場について調査・分析したレポートで、種類別（グルココルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...
  • 世界の多嚢胞性卵巣症候群の治療市場：市場規模・現状・予測
    Global Polycystic Ovarian Syndrome Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7857 2019年6月14日 99Pages
    当資料は、多嚢胞性卵巣症候群の治療のグローバル市場について調査・分析したレポートで、種類別（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、その他）、用途別（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南ア...
  • 世界のセロトニン症候群の治療市場：市場規模・現状・予測
    Global Serotonin Syndrome Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8022 2019年6月14日 97Pages
    当資料は、セロトニン症候群の治療のグローバル市場について調査・分析したレポートで、種類別（セロトニン拮抗薬、支持療法、消化管除染、その他）、用途別（病院での使用、診療所での使用、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...
  • 世界の発作性上室性頻拍市場：市場規模・現状・予測
    Global Paroxysmal Supraventricular Tachycardia Market Size, Status and Forecast 2019-2025
    QYR9N7767 2019年6月14日 92Pages
    当資料は、発作性上室性頻拍のグローバル市場について調査・分析したレポートで、種類別（AV結節再入性頻拍（AVNRT）、AV往復頻脈（AVRT）、発作性心房頻拍（PAT）、ウォルフ - パーキンソン - ホワイト症候群（WPW））、用途別（病院と診療所、診断センター、医学研究センター）、主要地域別（ア...
  • 世界のスタージウェーバー症候群（SWS）治療市場：市場規模・現状・予測
    Global Sturge Weber Syndrome (SWS) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8087 2019年6月14日 98Pages
    当資料は、スタージウェーバー症候群（SWS）治療のグローバル市場について調査・分析したレポートで、種類別（薬、レーザー治療、外科処置）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含ま...